NOT KNOWN FACTS ABOUT KDM5A-IN-1

quinupristin/dalfopristin will increase the level or outcome of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unfamiliar.quinupristin/dalfopristin will boost the degree or influence of acalabrutinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Carefully. Lessen ac